Astria Therapeutics, Inc.

Q4 2025 13F Holders

Symbol
ATXS
CUSIP
04635X102
Type
Equity
Class
COM
Num filings
144
Total reported value, excl. options
$739 M
Manager Report Date Value ($000) Shares Option Type